Status:
TERMINATED
Pilot Assessment of Lopinavir/Ritonavir and Maraviroc
Lead Sponsor:
Rodwick, Barry M., M.D.
Collaborating Sponsors:
Abbott
Conditions:
HIV Infections
Acquired Immunodeficiency Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a study to assess the response of lopinavir/ritonavir plus maraviroc (with no nucleoside medications) in HIV patients failing their initial antiviral therapy.
Detailed Description
As long-term toxicity to many of the nucleoside medications have become known, interest has increased in treatment regimens that do not use these medications. This study is to assess the response of o...
Eligibility Criteria
Inclusion
- HIV viral load \> 1,000 on current antiviral medications
- No resistance to study medications
- Over 18 years of age
Exclusion
- Hepatitis B co-infection
- Pregnancy
- Previous therapy with either of the study medications
- Ongoing substance abuse
- Significant history of other physical disease
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT00981318
Start Date
December 1 2009
End Date
May 1 2015
Last Update
June 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barry M. Rodwick, M. D.
Safety Harbor, Florida, United States, 34695